Essentials Mediapost

Marketing & Advertising in China News

Marketing & Advertising in China - Essentials is your daily digest curating the most insightful news hand-picked by top trusted experts in the industry.

Top news of the week: 10.03.2022.

Hong Kong
Mainland
Limit
Brand
Money
New York City

Marketing & Advertising In China

@caixin shared
On Mar 7, 2022
China Meheco confirmed talks with Pfizer on selling Paxlovid in China after the state-owned drug company’s shares surged in Shanghai by the 10% limit on four straight days. https://t.co/mClNDeK28G
Open
China Meheco Confirms Pfizer Talks on Selling Paxlovid in China - Caixin Global

China Meheco Confirms Pfizer Talks on Selling Paxlovid in China - Caixin Global

China Meheco Confirms Pfizer Talks on Selling Paxlovid in China - State-owned drugmaker’s shares surge by 10% limit on four straight days in Shanghai, though its role may be limited to ...

@ReutersChina shared
On Mar 8, 2022
Lego sales jump 27% in 2021, boosted by new China stores https://t.co/FipP0JvgeV
Open
Lego sales jump 27% in 2021, boosted by new China stores

Lego sales jump 27% in 2021, boosted by new China stores

Lego's sales jumped 27% last year driven by new store openings in China and customers flocking back to its reopened shops but are expected to normalise this year, the toymaker said on ...

@SCMPNews shared
On Mar 8, 2022
Beijing latest Chinese city to report improved land sales, rising property sector sentiment https://t.co/xyfpox7znK
Open
Fewer plot withdrawals, increase in premiums suggest the marketing is warming up, analyst says

Fewer plot withdrawals, increase in premiums suggest the marketing is warming up, analyst says

China’s land sales reported a slight recovery last month following the introduction of easing measures across the country.

@SCMPNews shared
On Mar 10, 2022
Chinese firm signs deal with Pfizer to supply Covid-19 pill https://t.co/3OsGB3d03q
Open
pill is one step closer to clinical use in China, with state-owned China Meheco Corp securing a deal with Pfizer to commercialise the drug within the year.

pill is one step closer to clinical use in China, with state-owned China Meheco Corp securing a deal with Pfizer to commercialise the drug within the year.

China’s drug regulator conditionally approved Paxlovid last month to treat adults with mild to moderate Covid-19 who are at high risk of becoming severely ill.

@SCMPNews shared
On Mar 7, 2022
China’s youthful beauty brands give themselves a facelift after initial success with clever marketing begins to fade https://t.co/tkwXYtfti1
Open
Chinese beauty brands expand e-commerce footprint in Southeast Asia

Chinese beauty brands expand e-commerce footprint in Southeast Asia

China’s home-grown beauty market is facing external and internal pressures, and at least a dozen online beauty brands, including Apinkbaby and Two Space, closed shop last year, media ...

@SCMPNews shared
On Mar 10, 2022
Baidu’s autonomous driving chief wants robotaxis to ditch human drivers, but regulatory hurdles are steep https://t.co/N5UCDeYm9a
Open
The internet search giant sees this as key to the commercial viability of robotaxis, which Baidu offers at a steep discount in select pilot zones around China

The internet search giant sees this as key to the commercial viability of robotaxis, which Baidu offers at a steep discount in select pilot zones around China

Baidu’s Wei Dong says the company is working with regulators to amend robotaxi regulations that require people behind the wheel, which could be an important development for commercial ...

@caixin shared
On Mar 9, 2022
CX Daily: Sanctions on Russia Sound Alarm for Chinese Banks - https://t.co/D47OVkX5pV https://t.co/gf657Rd88D
Open
Sanctions on Russia sound alarm for Chinese banks

Sanctions on Russia sound alarm for Chinese banks

China’s creating a financial security fund. Refined oil prices in the nation soar to near 10-year highs. China Meheco Corp. is in talks on selling Paxlovid in China. Plus, more wealthy ...

@SCMPNews shared
On Mar 6, 2022
Fake news causing rift between Chinese and foreigners: top Beijing adviser https://t.co/7s4DhbXz3Q
Open
to gain satisfaction from the online attention and clicks, and such posters also tended to exhibit a narrow, nationalistic mentality, he said.

to gain satisfaction from the online attention and clicks, and such posters also tended to exhibit a narrow, nationalistic mentality, he said.

Rampant sharing of fake information has had ‘serious impact’ on interests of China and its society, key member of country’s top advisory body says.